logo-loader
viewZoetic International PLC

Directorate Change

/**/ h2{margin-right:0cm;margin-left:0cm;font-size:18.0pt;font-family:"Times New Roman","serif";font-weight:bold;}p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue }visited{ color: #954F72 } .cj{size:595.3pt 841.9pt;margin:35.45pt 72.0pt 72.0pt 72.0pt;}div.cj{}p.dj{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify}span.dh{font-size:11.0pt; font-family:"Calibri","sans-serif"}p.dk{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold}span.df{font-size:11.0pt;font-family:"Calibri","sans-serif"}span.dl{font-size:11.0pt;font-family:"Calibri","sans-serif";color:black}span.dc{font-size:11.0pt; font-family:"Calibri","sans-serif";color:black}p.dm{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; margin: 0cm; margin-bottom: .0001pt; text-align: center}p.dn{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin: 0cm; margin-bottom: .0001pt; text-align: center} span.do{font-size:11.0pt;font-family:"Calibri","sans-serif"; color:black}p.dp{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; margin: 0cm; margin-bottom: .0001pt}span.cy{font-size: 11.0pt;font-family:"Calibri","sans-serif"}p.dq{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt;text-align:justify; line-height:17.0pt}p.dr{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify;line-height:17.0pt}p.ds{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;margin-right:0cm;margin-bottom:0cm; margin-left:36.0pt;margin-bottom:.0001pt;text-align:justify;text-indent:-18.0pt; line-height:17.0pt}span.cu{font-size:11.0pt;font-family:Symbol}p.dt{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; line-height: 17.0pt; margin: 0cm; margin-bottom: .0001pt; text-align: justify}p.du{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify;background:white}span.cr{font-size:11.0pt;font-family:"Calibri","sans-serif";color:#212121} p.dv{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif"; font-weight: bold; text-align: center}p.a,li.a,div.a{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";}p.dw{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; margin: 0cm; margin-bottom: .0001pt; text-align: justify}span.dd{font-size:11.0pt;font-family:"Calibri","sans-serif";color:black}p.dx{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt;text-align:justify}p.dy{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin:0cm;margin-bottom:.0001pt;text-align:justify; line-height:17.0pt}span.cm{color:black}p.dz{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";line-height:17.0pt}p.ea{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;margin-right:0cm;margin-bottom:5.0pt; margin-left:36.0pt;text-align:justify;line-height:17.0pt} /**/
RNS Number : 5248M
Zoetic International PLC
17 September 2019
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

17 September 2019

 

Zoetic International plc

("Zoetic International" or the "Company")

 

Directorate Change

 

Zoetic International, the London listed vertically integrated CBD and natural resources company, is pleased to announce that Paul Mendell has been appointed to the Board as Non-Executive Chairman.

 

Mr. Mendell has been involved with the Company since its IPO and has been instrumental in both the identification of its natural resources projects as well as taking a lead role in establishing the CBD business, particularly by identifying the significant potential of Zoetic International's nitrogen-hydrogen gas discovery in Kansas. He was also the co-founder of Iofina plc and, prior to a recent acquisition, owned interests in over 250 horizontal and vertical producing oil and gas wells in the US.

 

Mr. Mendell has waived any remuneration for his role until the earlier of six months' time or the Company's share price reaching 14 pence.

 

Following Mr. Mendell's appointment, the Board has established an executive management committee who will be responsible for overseeing the day-to-day operations of the Company. This comprises:

 

·    Nick Tulloch - CEO

·    Trevor Taylor - Chief Strategy Officer

·    Antonio Russo - Chief Revenue Officer

·    Eric Anderson - Senior Vice President

·    Melvyn Davies - returns to the Company as Interim CFO

 

Mr. Taylor and Mr. Russo have primary responsibility for the Company's CBD business and Mr. Anderson has primary responsibility for the Company's natural resources assets.

 

Nick Tulloch, Chief Executive Officer of Zoetic International, said: "I am delighted to welcome Paul to his new role with us. Since we announced our new strategy two weeks ago, Paul has been an enormous support. He has an in depth understanding of both sides of our business and, in particular, no one has as much knowledge of our natural resource assets, and of how to monetise them, as Paul. He is popular with our team and business partners and I am looking forward to working with him to deliver value to shareholders.

 

"We have a new name, a new strategy and a refocussed management team. While we are under no illusion about the scale of the task ahead of us, we are confident that our CBD business can be built into a highly profitable operation and that during that period it can be supported by realising value from our natural resources assets."

 

Listing Rule 9.6.13 disclosures

Zoetic International confirms that there are no disclosures to be made in respect of Paul Mendell for the purposes of Listing Rule 9.6.13.

 

**ENDS**

 

Enquiries

 

Zoetic International plc                                                                                                +44 (0) 1738 472 029

Nick Tulloch

 

Cantor Fitzgerald Europe                                                                                            +44 (0) 20 7894 7000        

David Porter      

                               

Newgate Communications                                                                                         +44 (0) 20 3757 6880

Elisabeth Cowell

Ian Silvera          

Fiona Norman  

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOAGGUMWBUPBPUQ

Quick facts: Zoetic International PLC

Price: 8.745

Market: LSE
Market Cap: £12.95 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Zoetic International's Nick Tulloch updates as it begins trading on the OTC

Zoetic International PLC's (LON:ZOE) Nick Tulloch speaks to Proactive London's Andrew Scott after they began trading on the over-the-counter (OTC) market in the USA. Tulloch says the OTC market in the US should help to increase the liquidity of its shares.  No new ordinary shares were...

1 day, 21 hours ago

RNS

Issue of Equity

1 day ago

Second Price Monitoring Extn

1 day, 19 hours ago

Price Monitoring Extension

1 day, 19 hours ago

Listing on the OTC

4 days, 2 hours ago

Issue of Equity

1 week ago

Notice of General Meeting

1 week, 1 day ago